Laboratory investigation of dysfunctional HDL

Chemistry and Physics of Lipids

Volumn 165, Issue 1, 2012, Pages 32-37

  Guo, Zhi Gang ^a   Li, Chen ^a   Zhong, Jian Kai ^a   Tu, Yan ^a   Xie, Di ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Coronary artery disease; Dysfunctional high density lipoprotein; Laboratory assessment

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ABC TRANSPORTER A1; ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL; DYSFUNCTIONAL HIGH DENSITY LIPOPROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SYNTHETASE; THROMBOXANE A2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD ANALYSIS; CELL ASSAY; CHOLESTEROL TRANSPORT; CYTOKINE PRODUCTION; DENSITY GRADIENT CENTRIFUGATION; DRUG DETERMINATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION REGULATION; HUMAN; LABORATORY TEST; LIPID ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; TWO DIMENSIONAL ELECTROPHORESIS;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; LIPOPROTEINS, HDL; PEROXIDASE;

EID: 82055191776     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2011.10.005     Document Type: Review

References (53)

1. B.J. Ansell, M. Navab, S. Hama, N. Kamranpour, G. Fonarow, G. Hough, S. Rahmani, R. Mottahedeh, R. Dave, S.T. Reddy, and A.M. Fogelman Inflammatory/anti-inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment Circulation 108 2003 2751 2756 (Pubitemid 37498976)
2. B.F. Asztalos, L.A. Cupples, S. Demissie, K.V. Horvath, C.E. Cox, M.C. Batista, and E.J. Schaefer High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study Arterioscler. Thromb. Vasc. Biol. 24 2004 2181 2187 (Pubitemid 39482449)
3. B.F. Asztalos, C.H. Sloop, L. Wong, and P.S. Roheim Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I containing subpopulations Biochim. Biophys. Acta 1169 1993 291 300 (Pubitemid 23264886)
4. P.J. Barter, M. Caulfield, M. Eriksson, M.G. Scott, J.J.P. Kastelein, M. Komajda, J.L. Sendon, L. Mosca, J.C. Tardif, D.D. Waters, C.L. Shear, J.H. Revkin, K.A. Buhr, M.R. Fisher, A.R. Tall, B. Brewer ILLUMINATE Investigators Effects of torcetrapib in patients at high risk for coronary events N. Engl. J. Med. 357 2007 2109 2122 (Pubitemid 350146106)
5. D. Danielle, and J.R. Daniel Update on strategies to increase HDL quantity and function Nat. Rev. Cardiol. 6 2009 455 463
6. W.S. Davidson, R.A.G.D. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, and A. Kontush Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters relevance to antioxidative function Arterioscler. Thromb. Vasc. Biol. 29 2009 870 876
7. M. Dobiasova, L. Adler, T. Ohta, and J. Frohlich Effect of labeling of plasma lipoproteins with [(3)H] cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma J. Lipid. Res. 41 2000 1356 1357 (Pubitemid 30666901)
8. S. Dodani, D.G. Grice, and B.S.S. Joshi Is HDL function as important as HDL quantity in the coronary artery disease risk assessment? J. Clin. Lipid 3 2009 70 77
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
10. A.S. Farid, K. Nakahara, N. Murakami, T. Hayashi, and Y. Horii Decreased serum paraoxonase-1 activity during intestinal nematode (nippostrongylus brasiliensis) infection in rats Am. J. Trop. Med. Hyg. 78 2008 770 776 (Pubitemid 351845135)
11. H. Feng, and X.A. Li Dysfunctional high density lipoprotein Curr. Opin. Endocrinol. Diabetes Obes. 16 2009 156 162
12. B. Föger, M. Chase, M.J. Amar, B.L. Vaisman, R.D. Shamburek, B. Paigen, J. Fruchart-Najib, J.A. Paiz, C.A. Koch, R.F. Hoyt, H.B. Brewer Jr., and S. Santamarina-Fojo Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice J. Biol. Chem. 274 1999 36912 36920
13. F.A. Francis The complexity of HDL Biochim. Biophys. Acta 1801 2010 1286 1293
14. J. Frohlich, and M. Dobiasova Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography Clin. Chem. 49 2003 1873 1880 (Pubitemid 37340322)
15. C. Gabay, and I. Kushner Acute-phase proteins and other systemic responses to inflammation N. Engl. J. Med. 340 1999 448 454 (Pubitemid 29084777)
16. M. Gomaraschi, D. Baldassarre, M. Amato, S. Eligini, P. Conca, C.R. Sirtori, G. Franceschini, and L. Calabresi Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I (Milano) mutant Circulation 116 2007 2165 2172 (Pubitemid 350060354)
17. Z.G. Guo, A. Inazu, W.X. Yu, A. Nohara, J. Koizumi, and H. Mabuchi A large deletion of ABC1 gene in a Japanese patient with tangier disease Atherosclerosis 151 2000 268
18. D.J. Hausenloy, and D.M. Yellon Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels Heart 94 2008 706 714 (Pubitemid 351744686)
19. R.J. Havel, H.A. Eder, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J. Clin. Invest. 34 1955 1345 1353
20. N. Hiroshi Latest insights into high-density lipoprotein function Endocrinologist 19 2009 179 186
21. J.M. Hoeg, S. Santamarina-Fojo, A.M. Bérard, J.F. Cornhill, E.E. Herderick, S.H. Feldman, C.C. Haudenschild, B.L. Vaisman, R.F. Hoyt Jr., S.J. Demosky Jr., R.D. Kauffman, C.M. Hazel, S.M. Marcovina, and H.B. Brewer Jr. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis PNAS 93 1996 11448 11453 (Pubitemid 26347141)
22. G.K. Hovingh, B.A. Hutten, A.G. Holleboom, W. Petersen, P. Rol, A. Stalenhoef, A.H. Zwinderman, E. de Groot, J.J. Kastelein, and J.A. Kuivenhoven Compromised LCAT function is associated with increased atherosclerosis Circulation 112 2005 879 884 (Pubitemid 41170075)
23. E.J. Jeyarajah, W.C. Cromwell, and J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin. Lab. Med. 26 2006 847 870 (Pubitemid 44716510)
24. S.A. Karabina, T.A. Liapikos, G. Grekas, J. Goudevenos, and A.D. Tselepis Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions Biochim. Biophys. Acta 1213 1994 34 38 (Pubitemid 24204562)
25. G.K. Marathe, G.A. Zimmerman, and T.M. McIntyre Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles J. Biol. Chem. 278 2003 3937 3947 (Pubitemid 36801125)
26. F. Matsuura, N. Wang, W. Chen, X.C. Jiang, and A.R. Tall HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway J. Clin. Invest. 116 2006 1435 1442
27. M.R. McCall, M.L. Belle, T.M. Forte, R.M. Krauss, Y. Takanami, and D.L. Tribble Dissociable and nondissociable forms of platelet activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility Biochim. Biophys. Acta 1 1999 23 36 (Pubitemid 29242900)
28. A.J. Mendez Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion J. Lipid Res. 38 1997 1807 1821 (Pubitemid 27411272)
29. M. Navab, G.M. Anantharamaiah, S.T. Reddy, S. Hama, G. Hough, V.R. Grijalva, A.C. Wagner, J.S. Frank, G. Datta, D. Garber, and A.M. Fogelman Oral D-4F causes formation of pre-β high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholestero transport from macrophages in apolipoprotein E-null mice Circulation 109 2004 3215 3220
30. M. Navab, G.M. Ananthramaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, G.C. Fonarow, K. Vahabzadeh, S. Hama, G. Hough, N. Kamranpour, J.A. Berliner, A.J. Lusis, and A.M. Fogelman The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL J. Lipid Res. 45 2004 993 1007 (Pubitemid 38679495)
31. J.R. Nofer, G.M. Van der, M. Tolle, I. Wolinska, L.K.V. Wnuck, H.A. Baba, U.J. Tieget, A. Gödecke, I. Ishii, B. Kleuser, M. Schäfers, M. Fobker, W. Zidek, G. Assmann, J. Chun, and B. Levkau HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 J. Clin. Invest. 113 2004 569 581 (Pubitemid 38542506)
32. B.J. O'Connell, and J. Genest Jr. High-density lipoproteins and endothelial function Circulation 104 2001 1978 1983 (Pubitemid 32983244)
33. J.D. Otvos, D. Collins, D.S. Freedman, I. Shalaurova, E.J. Schaefer, J.R. McNamara, H.E. Bloomfield, and S.J. Robins Low density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High Density Lipoprotein Intervention Trial Circulation 113 2006 1556 1563 (Pubitemid 43739414)
34. B. Pauls, and J.J. Albers Precipitation methods for quantification of lipoproteins Methods Enzymol. 129 1986 78 100 (Pubitemid 16055941)
35. S. Ragbir, and J.A. Farmer Dysfunctional high-density lipoprotein and atherosclerosis Curr. Atheroscler. Rep. 12 2010 343 348
36. M. Rajesh, and J.R. Daniel Laboratory assessment of HDL heterogeneity and function Clin. Chem. 54 2008 788 800
37. W. Richard, and S.P. James The importance of high-density lipoprpteins for paraoxonase-1 secretion, stability, and activity Free Radical Biol. Med. 37 2004 1986 1994
38. Q. Rozenn, G. Bart, S. Dominique, A. Mertens, M. Lox, G. Theilmeier, C. Michiels, M. Raes, H. Bult, D. Collen, P.V. Veldhoven, E. Ninio, and P. Holvoet Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice Circulation 5 2001 2495 2500 (Pubitemid 32493377)
39. S. Santamarina-Fojo, G. Lamber, J.M. Hoeg, and H.B. Brewer Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis Curr. Opin. Lipidol. 11 2000 267 275 (Pubitemid 30336024)
40. B. Shao, M.N. Oda, J.F. Oram, and J.W. Heinecke Myeloperoxidase an inflammatory enzyme for generating dysfunctional high density lipoprotein Curr. Opin. Cardiol. 21 2006 322 328 (Pubitemid 44315065)
41. I.M. Singh, M.H. Shishehbor, and B.J. Ansell High-density lipoprotein as a therapeutic target JAMA 298 2007 786 798
42. V. Stefano, S.G. Leveille, M.C. Corti, T.B. Harris, and J.M. Guralnik The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol J. Am. Geriatr. Soc. 49 2001 1142 1147 (Pubitemid 32900139)
43. D. Sviridov, N. Mukhamedova, A.T. Remaley, J. Chin-Dusting, and P. Nestel Antiatherogenic functionality of high density lipoprotein: how much versus how good J. Atheroscler. Thromb. 15 2008 52 62
44. B.L. Trigatti, M. Krieger, and A. Rigotti Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis Arterioscler. Thromb. Vasc. Biol. 23 2003 1732 1738 (Pubitemid 37254855)
45. T.N. Tulenko, and A.E. Sumner The physiology of lipoproteins J. Nucl. Cardiol. 9 2002 638 649 (Pubitemid 36050211)
46. B.J. Van Lenten, A.C. Wagner, D.P. Naak, S. Hama, M. Navab, and A.M. Fogelman High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection Circulation 103 2001 2283 2288 (Pubitemid 32433719)
47. A. Watson, J. Berliner, S. Hama, B.L. Du, K.F. Faull, A.M. Fogelman, and M. Navab Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein J. Clin. Invest. 96 1995 2882 2891
48. A. Zalewski, and C. Macphee Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target Arterioscler. Thromb. Vasc. Biol. 25 2005 923 931 (Pubitemid 40627835)
49. Y.Z. Zhang, J.R. Da Silva, M. Reilly, J.T. Billheimer, G.H. Rothblat, and D.J. Rader Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo J. Clin. Invest. 115 2005 2870 2874 (Pubitemid 41434414)
50. L. Zheng, B. Nukuna, M.L. Brennan, M.J. Sun, M. Goormastic, M. Settle, D. Schmitt, X.M. Fu, L. Thomson, P.L. Fox, H. Ischiropoulos, J.D. Smith, M. Kinter, and S.L. Hazen Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease J. Clin. Invest. 114 2004 529 541 (Pubitemid 39572103)
51. G. Zuliani, E. Palmieri, S. Volpato, G. Bader, A. Mezzetti, F. Costantini, G.R. Sforza, T. Imbastaro, F. Romagnoni, and R. Fellin High-density lipoprotein cholesterol strongly discriminates between healthy free-living and disabled octo-nonagenarians. A cross-sectional study Aging Clin. Exp. Res. 9 1997 335 341
52. G. Zuliani, F. Romagnoni, C. Bollini, V. Leoci, L. Soattin, and R. Fellin Low levels of high-density lipoprotein cholesterol are a marker of disability in the elderly Gerontology 45 1999 317 322 (Pubitemid 29516073)
53. G. Zuliania, S. Volpato, A. Bl, S. Bandinelli, A.M. Corsi, F. Lauretani, G. Paolisso, R. Fellin, and L. Ferrucci High interleukin-6 plasma levels are associated with low HDL-C levels in community dwelling older adults: the In Chianti Study Atherosclerosis 192 2007 384 390 (Pubitemid 46735937)